U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

DUNALIELLA BARDAWIL

MORE DETAILS

3P5RK1P132

structurally diverse
Status:
Investigational
Source:
NCT01628081: Phase 3 Interventional Unknown status Psoriasis
(2012)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT01628081
Class:
STRUCTURALLY DIVERSE

DUNALIELLA SALINA

MORE DETAILS

F4O1DKI9A6

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2001)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ba437d1-d96f-4235-bebf-611eb09ea11d
First approved in 2001
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ba437d1-d96f-4235-bebf-611eb09ea11d
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966